Loading viewer...
investor_presentation
Format: PDF investor_presentation
Inotiv is a contract research organization (CRO) providing discovery, safety assessment, and research model services to biopharmaceutical companies. The company operates two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS), helping clients reduce time and cost in drug development. Founded in 1974 and reinvented in 2017, Inotiv serves approximately 3,500 customers with over 2,100 employees.
investor_presentation
25 Pages
Prestige Estates Q1 FY24 Investor Presentation
investor_presentationinvestor_presentation
44 Pages
Prestige Estates Projects
HDFC Nifty LargeMidcap 250 Index Fund 2024 Launch
investor_presentationinvestor_presentation
20 Pages
HDFC Asset Management Company